Fed. Cir. Upholds Ravgen DNA Test Patent Challenged by Labcorp

The Federal Circuit rejected Laboratory Corporation of America Holdings’ challenge of a competitor’s fetal DNA test patent underlying a Texas jury’s previous $273 million verdict against the diagnostics giant.

The US Court of Appeals for the Federal Circuit affirmed a Patent Trial and Appeal Board ruling rejecting a challenge to US Patent No. 7,332,277 on Monday in an opinion written by Judge Alan D. Lourie and joined by Judges William C. Bryson and Leonard P. Stark.

Labcorp was found in late 2022 to have infringed Ravgen Inc.'s method of screening for Down syndrome and other genetic abnormalities captured in ...